Form4insider filings, from the source

SEC Form 4 · accession 0001178913-26-003508

Entera Bio Ltd. · ENTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Miranda Jayne Toledano
Officer — Chief Executive Officer · Director
Period of report
Jul 14, 2026
Accepted (ET)
Jul 16, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001638097

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary Shares, par value NIS 0.0000769 per shareF1Jul 14, 2026A347,567$0.00A774,142D
Ordinary Shares, par value NIS 0.0000769 per shareF2Jul 14, 2026A72,993$0.00A847,135D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses